Biochemical surrogates of NAFLD, γ-glutamyl transferase (GGT) and ALT, predict the incidence of coronary artery disease and other cardiovascular disease, which is further elevated in NAFLD patients who suffer co-morbidly with diabetes mellitus [11]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.